• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒在心肌梗死预防和治疗中的研究进展。

Advances in Nanoparticles in the Prevention and Treatment of Myocardial Infarction.

机构信息

College of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.

出版信息

Molecules. 2024 May 21;29(11):2415. doi: 10.3390/molecules29112415.

DOI:10.3390/molecules29112415
PMID:38893291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11173599/
Abstract

Myocardial infarction (MI) is one of the most prevalent types of cardiovascular disease. During MI, myocardial cells become ischemic and necrotic due to inadequate blood perfusion, leading to irreversible damage to the heart. Despite the development of therapeutic strategies for the prevention and treatment of MI, their effects are still unsatisfactory. Nanoparticles represent a new strategy for the pre-treatment and treatment of MI, and novel multifunctional nanoparticles with preventive and therapeutic capabilities hold promise for the prevention and treatment of this disease. This review summarizes the common types and properties of nanoparticles, and focuses on the research progress of nanoparticles for the prevention and treatment of MI.

摘要

心肌梗死(MI)是最常见的心血管疾病类型之一。在 MI 中,由于血液灌注不足,心肌细胞发生缺血和坏死,导致心脏不可逆转的损伤。尽管已经开发出用于 MI 的预防和治疗的治疗策略,但它们的效果仍然不尽人意。纳米颗粒代表了 MI 的预处理和治疗的新策略,具有预防和治疗功能的新型多功能纳米颗粒有望预防和治疗这种疾病。本综述总结了纳米颗粒的常见类型和特性,并重点介绍了用于 MI 的预防和治疗的纳米颗粒的研究进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b63/11173599/e7b6691fe08f/molecules-29-02415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b63/11173599/61bf1b2f5288/molecules-29-02415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b63/11173599/e7b6691fe08f/molecules-29-02415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b63/11173599/61bf1b2f5288/molecules-29-02415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b63/11173599/e7b6691fe08f/molecules-29-02415-g002.jpg

相似文献

1
Advances in Nanoparticles in the Prevention and Treatment of Myocardial Infarction.纳米颗粒在心肌梗死预防和治疗中的研究进展。
Molecules. 2024 May 21;29(11):2415. doi: 10.3390/molecules29112415.
2
Nanoparticles: Promising Tools for the Treatment and Prevention of Myocardial Infarction.纳米颗粒:心肌梗死治疗和预防的有前途的工具。
Int J Nanomedicine. 2021 Oct 1;16:6719-6747. doi: 10.2147/IJN.S328723. eCollection 2021.
3
Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches.用于动脉粥样硬化和心肌梗死的诊断和治疗的纳米颗粒:向有前途的治疗诊断方法的演进。
Theranostics. 2018 Sep 9;8(17):4710-4732. doi: 10.7150/thno.26284. eCollection 2018.
4
Recent advances and future directions in myocardial infarction.心肌梗死的最新进展与未来方向
Cardiology. 1994;84(6):391-407. doi: 10.1159/000176431.
5
Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation.含秋水仙碱的纳米颗粒通过抑制炎症减轻急性心肌梗死损伤。
Cardiovasc Drugs Ther. 2022 Dec;36(6):1075-1089. doi: 10.1007/s10557-021-07239-2. Epub 2021 Aug 26.
6
Curcumin Nanoparticles Protect against Isoproterenol Induced Myocardial Infarction by Alleviating Myocardial Tissue Oxidative Stress, Electrocardiogram, and Biological Changes.姜黄素纳米粒子通过减轻心肌组织氧化应激、心电图和生物学变化来保护异丙肾上腺素诱导的心肌梗死。
Molecules. 2019 Aug 1;24(15):2802. doi: 10.3390/molecules24152802.
7
MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction.具有潜在应用于磁共振成像和心肌梗死药物递送的 MnO 纳米颗粒。
Int J Nanomedicine. 2018 Oct 8;13:6177-6188. doi: 10.2147/IJN.S176404. eCollection 2018.
8
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.动脉粥样硬化血栓形成风险分层以及vorapaxar在稳定型缺血性心脏病和既往心肌梗死患者中的疗效与安全性
Circulation. 2016 Jul 26;134(4):304-13. doi: 10.1161/CIRCULATIONAHA.115.019861.
9
Polymeric nanoparticles in the diagnosis and treatment of myocardial infarction: Challenges and future prospects.聚合物纳米颗粒在心肌梗死诊断与治疗中的应用:挑战与未来展望
Mater Today Bio. 2022 Apr 4;14:100249. doi: 10.1016/j.mtbio.2022.100249. eCollection 2022 Mar.
10
Rescuing Cardiac Cells and Improving Cardiac Function by Targeted Delivery of Oxygen-Releasing Nanoparticles after or Even before Acute Myocardial Infarction.通过急性心肌梗死后甚至之前靶向递供氧释放纳米颗粒来拯救心脏细胞和改善心脏功能。
ACS Nano. 2022 Nov 22;16(11):19551-19566. doi: 10.1021/acsnano.2c10043. Epub 2022 Nov 11.

引用本文的文献

1
Plant-derived secondary metabolites and nanotechnology: innovative strategies and emerging challenges in myocardial ischemia-reperfusion injury therapy.植物源次生代谢产物与纳米技术:心肌缺血再灌注损伤治疗中的创新策略与新挑战
Front Pharmacol. 2025 May 29;16:1529478. doi: 10.3389/fphar.2025.1529478. eCollection 2025.
2
Inflammatory Cell-Targeted Delivery Systems for Myocardial Infarction Treatment.用于心肌梗死治疗的炎症细胞靶向递送系统
Bioengineering (Basel). 2025 Feb 19;12(2):205. doi: 10.3390/bioengineering12020205.
3
Prediction of in-hospital mortality risk for patients with acute ST-elevation myocardial infarction after primary PCI based on predictors selected by GRACE score and two feature selection methods.

本文引用的文献

1
Myocardial Ischemia-Reperfusion Injury: Unraveling Pathophysiology, Clinical Manifestations, and Emerging Prevention Strategies.心肌缺血再灌注损伤:解析病理生理学、临床表现及新兴预防策略
Biomedicines. 2024 Apr 4;12(4):802. doi: 10.3390/biomedicines12040802.
2
Engineered bone marrow mesenchymal stem cell-derived exosomes loaded with miR302 through the cardiomyocyte specific peptide can reduce myocardial ischemia and reperfusion (I/R) injury.工程化骨髓间充质干细胞来源的外泌体通过心肌细胞特异性肽负载 miR302 可减轻心肌缺血再灌注(I/R)损伤。
J Transl Med. 2024 Feb 17;22(1):168. doi: 10.1186/s12967-024-04981-7.
3
Myocardial ischemia/reperfusion: Translational pathophysiology of ischemic heart disease.
基于GRACE评分及两种特征选择方法筛选出的预测因子对急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后院内死亡风险的预测
Front Cardiovasc Med. 2024 Oct 22;11:1419551. doi: 10.3389/fcvm.2024.1419551. eCollection 2024.
4
Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium.纳米载体在血管系统中靶向药物递送的应用:聚焦于内皮细胞。
J Nanobiotechnology. 2024 Oct 12;22(1):620. doi: 10.1186/s12951-024-02892-9.
5
HDAC7 promotes cardiomyocyte proliferation by suppressing myocyte enhancer factor 2.组蛋白去乙酰化酶7通过抑制肌细胞增强因子2来促进心肌细胞增殖。
J Mol Cell Biol. 2025 May 2;16(10). doi: 10.1093/jmcb/mjae044.
心肌缺血/再灌注:缺血性心脏病的转化病理生理学。
Med. 2024 Jan 12;5(1):10-31. doi: 10.1016/j.medj.2023.12.007.
4
Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape.mRNA 纳米颗粒技术:递呈策略、临床应用和发展前景。
Theranostics. 2024 Jan 1;14(2):738-760. doi: 10.7150/thno.84291. eCollection 2024.
5
Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective.纳米载体治疗心肌缺血再灌注损伤的多种递药策略:当前策略与未来展望。
Drug Deliv. 2024 Dec;31(1):2298514. doi: 10.1080/10717544.2023.2298514. Epub 2023 Dec 26.
6
Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-κB/NLRP3 pathways in inflammatory endothelial cells.新型纳米颗粒平台递送秋水仙碱通过靶向抑制炎症性内皮细胞中的 NF-κB/NLRP3 通路缓解动脉粥样硬化。
J Nanobiotechnology. 2023 Nov 30;21(1):460. doi: 10.1186/s12951-023-02228-z.
7
Current Overview of Metal Nanoparticles' Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles.金属纳米颗粒的合成、表征及生物医学应用的当前概述,重点关注银和金纳米颗粒
Pharmaceuticals (Basel). 2023 Oct 4;16(10):1410. doi: 10.3390/ph16101410.
8
Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis.仿生纳米颗粒增强胆固醇逆向转运,选择性抑制动脉粥样硬化泡沫细胞的形成。
J Nanobiotechnology. 2023 Aug 29;21(1):307. doi: 10.1186/s12951-023-02040-9.
9
Nanoparticles in Medicine: Current Status in Cancer Treatment.医学纳米粒子:癌症治疗的当前现状。
Int J Mol Sci. 2023 Aug 15;24(16):12827. doi: 10.3390/ijms241612827.
10
Nanogels as novel drug nanocarriers for CNS drug delivery.纳米凝胶作为用于中枢神经系统药物递送的新型药物纳米载体。
Front Mol Biosci. 2023 Aug 8;10:1232109. doi: 10.3389/fmolb.2023.1232109. eCollection 2023.